Rare diseases
Investigational molecules
Locations
Back to Austria90 clinical trials in Wels, Austria. Every trial is listed in the EU Clinical Trials Register and updated daily.
AustriaA Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety
AustriaA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
AustriaStudy on the Effects of Pegozafermin for Patients with Nonalcoholic Steatohepatitis (NASH) and Fibrosis
AustriaStudy of Tucatinib, Trastuzumab, and mFOLFOX6 for Patients with HER2+ Metastatic Colorectal Cancer
AustriaEfficacy and Safety of Oral PIPE-791 in Adults with Idiopathic Pulmonary Fibrosis: A Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study
AustriaFirst‑line Study of RMC‑9805 with Investigator’s Choice Chemotherapy Drug Combination vs Chemotherapy Alone in Patients with Metastatic KRAS G12D‑Mutated Pancreatic Adenocarcinoma
AustriaA Phase 3 Study of Sapablursen Compared with Placebo in Adults with Polycythemia Vera
AustriaEfficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis
AustriaEffect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)
AustriaA Phase 3b Study of Guselkumab Compared with Risankizumab in Adults with Moderately to Severely Active Crohn’s Disease
AustriaEIK1005 Alone and with Pembrolizumab for Advanced Solid Tumors in Patients with MSI-H or dMMR Tumors
AustriaThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on metastatic prostate cancer, breast cancer, and various types of lung cancer, testing new therapeutic approaches and combination treatments.
Multiple studies evaluating novel targeted therapies and immunotherapy combinations for better patient outcomes.
Research targeting Crohn's Disease, ulcerative colitis, and rheumatic diseases with innovative therapeutic approaches.
Trials exploring new treatment options for inflammatory and autoimmune conditions affecting various organ systems.
Clinical investigations into lymphomas, leukemia, and other blood disorders, testing novel therapeutic combinations.
Advanced research into targeted therapies for various hematological malignancies and disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
